User Reviews for Certolizumab to treat Crohn's Disease
Also known as: Cimzia
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Reviews for Certolizumab
Cimzia (certolizumab): "I initially took Cimzia as part of a clinical trial. During the trial, we received a full dose (400 mg) every 2 weeks but, once it was available on the market, the dose was only 400 mg every 4 weeks (or 200 mg every 2 weeks). The medicine wore off before the 4 weeks was up, so I switched to Humira, which worked much better. Now that I've had rare side effects to Humira (and already failed Remicade), I've had to switch back to Cimzia. It is only working for about a week and a half of the four weeks (at 400 mg). I hope to find another alternative, as this isn't worth it."
Cimzia (certolizumab): "When all else failed (I had done Asacol and Remicade along with 6-mp and other treatments; Remicade did well at first but over time stopped working) I have found this medicine to be a great replacement for Remicade. The nurse comes to the house so its more convenient. The only down side is that it's injected intramuscularly and not I.V."
Learn more about Crohn's Disease
Symptoms and treatments
Drugs.com Health Center
Mayo Clinic Reference
ICD-10 CM Clinical Codes (External)
More about certolizumab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 32 Reviews
- Drug class: TNF alfa inhibitors
- FDA Alerts (4)
- Certolizumab Prefilled Syringes
- Certolizumab Vials
- Certolizumab Subcutaneous (Advanced Reading)
Other brands: Cimzia